The Rega Institute was founded in 1954 by Professor Piet De Somer and named after the 18th century filantropist and professor Josephus Rega of Leuven. It hosts part of the Department of Microbiology and Immunology. Since its inception, the Rega Institute hosts also the Section of Medicinal Chemistry of the Department of Pharmaceutical Sciences and is thus a true interdepartmental and interdisciplinary research institute. The Rega Institute has always been a jewel in the crown of research and innovation at the University of Leuven on the basis of publications, citations and prestigious scientific prizes of its members. For a brief history and research accomplishments at the Rega Institute and the Department of Microbiology and Immunology, the reader is referred to the portfolio, edited at the occasion of the 50th anniversary in 2004, and to the Rega Institute Bibliography with more than 5700 research publications in 2013. The rich history of the Department of Microbiology and Immunology has evolved by interdisciplinary research. Professor P. De Somer (1917-1985), who was re-elected rector of the University three times, always kept a heart for breakthrough research and combined the visions of an entrepreneur and academician. Thanks to his efforts as a virologist, Belgium became the first country in the world where poliomyelitis was eradicated. Trained as a medical doctor, he had the insights to bring medicinal chemistry (Prof. H. Vanderhaeghe, 1921-1992) and later molecular biology to the Institute and the University.
Editors [1]
The following is the list of scholars from Rega Institute for Medical Research who currently serve as editors for one or more SciTechnol journals.
Publications [31]
The following is the list of articles by scholars from Rega Institute for Medical Research that are published in SciTechnol journals.
-
Antiviral Drug Monitoring: Paving the Path to Precision Medicine in Viral Infections
Perspective: J Virol Antivir
DOI:
Ismail Akhtar
-
The Remarkable Rise in Use of Viruses in Potential Medicine
Perspective: J Virol Antivir
DOI:
Sergi Leserno
-
The Dual Role of Antivirals and Vaccines in Treatment and Prevention
Commentary: J Virol Antivir
DOI:
Kyoko Iworimoto
-
Understanding the Complex Anatomy of the H1N1 Influenza Virus
Short Communication: J Virol Antivir
DOI:
Madelon Alauring
-
Monkey Fever: Understanding Kyasanur Forest Disease
Perspective: J Virol Antivir
DOI:
Devendra Univenkappa
-
HIV and the Immune System: A Struggle of Complexity and Resilience
Opinion Article: J Virol Antivir
DOI:
Serena Lellinge
-
A Quiet Pandemic: Crimean-Congo Haemorrhagic Fever
Perspective: J Virol Antivir
DOI:
Vorica Heimann
-
The Role of Viral Shedding in Disease Transmission
Opinion Article: J Virol Antivir
DOI:
Norifumi Suto
-
Viral Proteomics: Decoding the Intricate World of Viral Proteins
Opinion Article: J Virol Antivir
DOI:
Stephan Phillips
-
RNA Interference (RNAi) Therapies for Rare Genetic Disorders: A Promising Frontier in Precision Medicine
Commentary: J Virol Antivir
DOI:
Lanier Corbin
-
Converging Paths: Unraveling the Link between Non-Alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis, and Potential Therapeutic Synergy
Perspective: J Virol Antivir
DOI:
Esteban Herbert
-
Unravelling the Power of Innate Immune Responses to Viral Infections: Safeguarding Our Health from the Outset
Opinion Article: J Virol Antivir
DOI:
Fang Fangchao
-
The Intricacies of Host-Virus Interaction: Implications for Health and Disease
Short Communication: J Virol Antivir
DOI:
Arif Alabdallah
-
Exploring the Complex Nexus: HIV and the Central Nervous System
Perspective: J Virol Antivir
DOI:
Lacy Schaeffer
-
Broad-Spectrum Antivirals: Paving the Way for Pandemic Preparedness
Opinion Article: J Virol Antivir
DOI:
Mathieu Tropsha
-
Advancing Antiviral Therapies and Understanding Immune Responses
Opinion Article: J Virol Antivir
DOI:
Chao Wang
-
Evaluation of N Gene, S Gene and ORF Based Real-Time RTPCR Assays by Taqpathcovid 19 Combo Kit for Confirmationof SARS-Cov-2 Infection: An Observational Study
Opinion Article: J Virol Antivir Res 2021, 10: (6)
DOI:
Jyoti Khurana*1 , Sulekha Yadav1 , Suman Kumar1 , Anita Mutha2 , Manish Purohit3 , Thang Sunil Ahirwar
-
Viral Therapy Advances for Treating Diseases
Opinion Article: J Virol Antivir Res
DOI:
Jong Dejian
-
The Potential of Host Defenses: Mechanisms and its Effects
Opinion Article: J Virol Antivir Res
DOI:
Roonei Cooter
-
Precise Gene Manipulation Using RNA Interference
Perspective: J Virol Antivir Res
DOI:
Tamang Logan
-
Novel Viral Proteomics Techniques and Discoveries
Short Communication: J Virol Antivir Res
DOI:
Olivin Roosar
-
Genetic Diversity in Viral Populations
Perspective: J Virol Antivir Res
DOI:
Jang Dinu
-
Current Advances and Challenges in Clinical Virology
Opinion Article: J Virol Antivir Res
DOI:
Mercier Bogers
-
Advancements in Viral Vector Technology for Gene Therapy
Opinion Article: J Virol Antivir Res
DOI:
Edar Agirre Beitia
-
Different Types of Hepatitis their Transmission and Prevention
Opinion Article: J Virol Antivir Res
DOI:
Crabb Hoepelman
-
New Frontiers in Anti-Viral Research
Perspective: J Virol Antivir Res
DOI:
Nerea Montagnani
-
The Science of Viral Diseases and Their Impact on Health
Short Communication: J Virol Antivir Res
DOI:
Jianguo Hasan
-
Entry of Hepatitis B Virus: Innovatory Treatment and their Antiviral Targets
Opinion Article: J Virol Antivir Res 2021, 10: (6)
DOI:
Asahi Ito
-
Viral Proteomics: Worldwide Assessment of Infections and their Interaction
Commentary: J Virol Antivir Res 2021, 10: (6)
DOI:
Qiang Cheung
-
Human Endogenous and Exogenous Retroviruses and clinical Manifestations
Short Communication: J Virol Antivir Res 2021, 10: (6)
DOI:
Adam Cohen
-
Structure and Genome Discovery of HIV Virus and Development of HIV-Protease Inhibitors
Perspective: J Virol Antivir Res 2021, 10: (6)
DOI:
Aegeus Chloros